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Awareness of folic acid use among pregnant women in
Taipei e Reply to letter to the EditorWe appreciate Dr. Tsai’s advice on our previous study [1]
and his extensive review on this topic. Dr. Tsai has pointed
out several important issues, and we would like to make
further discussions here.
First of all, Taiwan is a low prevalence area for neural tube
defects (NTDs) and the potential adverse events due to folic acid
fortification on other vulnerable populations must be seriously
considered according to The Netherlands’ experience [2].
However, the experience of Mainland China, which essentially
involves a similar ethnic race as Taiwan’s, has revealed that the
folic acid supplementations can effectively reduce the incidence
of NTDs in both high and low prevalence areas [3]. In addition,
there is no statistical analysis to show the association between
periconceptional use and positional plagiocephaly for a small
study group in the Netherland study [2], and, currently, there are
no other clinical observations supporting these findings. Authors
of the study attributed the possible association to a double use of
folic acid supplements dose but not folic acid fortification. The
additional intake of approximate 100 mg/day folic acid through
food fortification can effectively reduce the incidence of fetal
NTDs among mothers with low folic acid intake [4], but it does
not add much to women who already take supplements. Food
fortification should not significantly increase the incidence of
possible adverse events.
Secondly, we agree that over the counter prenatal vitamins or
other supplements containing 400 mg to 1 mg of folic acid are
readily available over the counter in Taiwan, andmanywomen do
take them. However, only 15% of women took folic acid before
pregnancy in our study [1]. The critical period for periconcep-
tional folic acid supplementations includes the period from about
1month before conception to early pregnancy. TheU.S. Food and
Drug Administration policy of folic acid fortification is based on
the facts that only a small proportion of women use folic acid
supplements before their pregnancies but about one-half of the
pregnancies are unplanned. The rate of periconceptional use of
folic acid in Taiwanese women is higher than other Asian coun-
tries in the periconceptional stage (Thailand, 9.7%; northern
region of China, 14.7%; Korea, 10.3%; Taiwan, 15.6% before
pregnancy and 90% during early pregnancy) [1,3,5,6]. We have
discussed the possible reasons in the discussion section of our
paper.1028-4559/$ - see front matter Copyright  2012, Taiwan Association of Obstetri
http://dx.doi.org/10.1016/j.tjog.2012.04.034Thirdly, a blood test to check folic acid levels may be
a more precise method for advising folic acid supplementa-
tion. However, it is invasive test and impractical. We seldom
advise vitamins use to patients based on blood levels in the
clinical practice. The recommended dietary reference intakes
(DRI) of folic acid for Taiwan was announced in 2011 [7].
We agree that Dr. Tsai’s suggestion of the statement “.may
be or probably is needed” is better than the assertivewords “.is
needed” that we used. However, our study also concluded “it is
warranted to evaluate the cost-effectiveness for a folic acid
fortification policy.” We also agree that detailed discussions and
probably extensive epidemiologic surveys are needed before an
important policy such as folic acid fortification is implemented,
and we all should encourage such discussion to achieve
a common consensus. The problem, however, is how much time
we should spend before taking action. Presently, most clinical
evidence and results of folic acid fortification policies in several
countries have revealed that food fortification of folic acid may
be the most cost-effective method to increase periconceptional
folic acid intake and to decrease the incidence of fetal NTDs.
Finally, we appreciate the suggestions and discussions from Dr.
Tsai and hope to see policy discussion on this topic in the near
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